• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环细菌DNA作为肺癌早期检测的血浆生物标志物

Circulating Bacterial DNA as Plasma Biomarkers for Lung Cancer Early Detection.

作者信息

Zhou Huifen, Liao Jipei, Leng Qixin, Chinthalapally Molangur, Dhilipkannah Pushpa, Jiang Feng

机构信息

Department of Pathology, University of Maryland School of Medicine, 10 South Pine Street, MSTF 7th Floor, Baltimore, MD 21201, USA.

Environmental Science and Technology, College of Agriculture and Natural Resources, University of Maryland, College Park, MD 20742, USA.

出版信息

Microorganisms. 2023 Feb 25;11(3):582. doi: 10.3390/microorganisms11030582.

DOI:10.3390/microorganisms11030582
PMID:36985157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10058358/
Abstract

Lung cancer is a leading cause of cancer deaths and early diagnosis can significantly improve outcomes. Pathogenic bacteria have been shown to play a role in tumorigenesis and its analysis provides a new approach for cancer diagnosis. To evaluate the potential of bacteria as plasma biomarkers for early lung cancer detection, we analyzed eight lung-cancer-related bacterial genera in 58 lung cancer patients and 58 controls using ddPCR. Our results showed that five genera had higher DNA abundance in lung tumor tissues compared with normal tissues. Three of these genera (, , and ) displayed consistent changes in plasma, with higher DNA abundance in lung cancer patients compared with controls. When used as a panel, these three bacterial genera had a sensitivity of 75% and specificity of 78% for lung cancer detection, regardless of stage or histology. The performance of this biomarker panel was confirmed in an independent cohort of 93 lung cancer cases and 93 controls. Thus, circulating bacterial DNA has the potential to be used as plasma biomarkers for early lung cancer detection.

摘要

肺癌是癌症死亡的主要原因,早期诊断可显著改善治疗结果。已证明致病细菌在肿瘤发生中起作用,对其进行分析为癌症诊断提供了一种新方法。为了评估细菌作为早期肺癌检测血浆生物标志物的潜力,我们使用数字滴液聚合酶链反应(ddPCR)分析了58例肺癌患者和58例对照中8个与肺癌相关的细菌属。我们的结果表明,与正常组织相比,5个属在肺肿瘤组织中的DNA丰度更高。其中3个属(、和)在血浆中表现出一致的变化,肺癌患者的DNA丰度高于对照组。当作为一个组合使用时,这3个细菌属对肺癌检测的敏感性为75%,特异性为78%,与分期或组织学无关。该生物标志物组合的性能在一个由93例肺癌病例和93例对照组成的独立队列中得到了证实。因此,循环细菌DNA有潜力用作早期肺癌检测的血浆生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a7d/10058358/b0acd76c7605/microorganisms-11-00582-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a7d/10058358/df464a432bb4/microorganisms-11-00582-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a7d/10058358/678e3fa0ae49/microorganisms-11-00582-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a7d/10058358/e133139958c0/microorganisms-11-00582-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a7d/10058358/6254b0271706/microorganisms-11-00582-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a7d/10058358/b0acd76c7605/microorganisms-11-00582-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a7d/10058358/df464a432bb4/microorganisms-11-00582-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a7d/10058358/678e3fa0ae49/microorganisms-11-00582-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a7d/10058358/e133139958c0/microorganisms-11-00582-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a7d/10058358/6254b0271706/microorganisms-11-00582-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a7d/10058358/b0acd76c7605/microorganisms-11-00582-g005.jpg

相似文献

1
Circulating Bacterial DNA as Plasma Biomarkers for Lung Cancer Early Detection.循环细菌DNA作为肺癌早期检测的血浆生物标志物
Microorganisms. 2023 Feb 25;11(3):582. doi: 10.3390/microorganisms11030582.
2
Microbiota Biomarkers for Lung Cancer.肺癌的微生物群生物标志物
Diagnostics (Basel). 2021 Feb 27;11(3):407. doi: 10.3390/diagnostics11030407.
3
MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).基于 microRNA 的生物标志物用于诊断非小细胞肺癌(NSCLC)。
Thorac Cancer. 2020 Mar;11(3):762-768. doi: 10.1111/1759-7714.13337. Epub 2020 Jan 28.
4
Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules.利用血浆进行超灵敏 DNA 高甲基化检测以早期发现 NSCLC:一项针对中国小肺结节患者的研究。
Clin Epigenetics. 2020 Mar 5;12(1):39. doi: 10.1186/s13148-020-00828-2.
5
Circulating tumor DNA detection is correlated to histologic types in patients with early-stage non-small-cell lung cancer.循环肿瘤 DNA 检测与早期非小细胞肺癌患者的组织学类型相关。
Lung Cancer. 2019 Aug;134:108-116. doi: 10.1016/j.lungcan.2019.05.034. Epub 2019 May 31.
6
Accurate detection of early-stage lung cancer using a panel of circulating cell-free DNA methylation biomarkers.使用一组循环游离DNA甲基化生物标志物准确检测早期肺癌。
Biomark Res. 2023 Apr 26;11(1):45. doi: 10.1186/s40364-023-00486-5.
7
Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity.IDH1 和 DNA 甲基化生物标志物在肺癌诊断中的转化价值:一种具有分期和组织学特异性的新型诊断标志物组合。
J Transl Med. 2019 Dec 30;17(1):430. doi: 10.1186/s12967-019-2117-7.
8
Cortisol, cortisone, and 4-methoxyphenylacetic acid as potential plasma biomarkers for early detection of non-small cell lung cancer.皮质醇、可的松和4-甲氧基苯乙酸作为早期检测非小细胞肺癌的潜在血浆生物标志物。
Int J Biol Markers. 2018 Aug;33(3):314-320. doi: 10.1177/1724600818778754. Epub 2018 Jun 13.
9
Plasma microRNAs as potential biomarkers for non-small-cell lung cancer.血浆 microRNAs 作为非小细胞肺癌的潜在生物标志物。
Lab Invest. 2011 Apr;91(4):579-87. doi: 10.1038/labinvest.2010.194. Epub 2010 Nov 29.
10
A Plasma Long Noncoding RNA Signature for Early Detection of Lung Cancer.一种用于肺癌早期检测的血浆长链非编码RNA特征
Transl Oncol. 2018 Oct;11(5):1225-1231. doi: 10.1016/j.tranon.2018.07.016. Epub 2018 Aug 8.

引用本文的文献

1
Improving CT scan for lung cancer diagnosis with an integromic signature.利用整合基因组特征改进用于肺癌诊断的CT扫描
J Biol Methods. 2024 Sep 6;11(3):e99010023. doi: 10.14440/jbm.2024.0028. eCollection 2024.
2
Integrative Biomarker Panel for Improved Lung Cancer Diagnosis Using Plasma microRNAs and Sputum Bacterial DNA.血浆 microRNAs 和痰液细菌 DNA 的综合生物标志物检测 panel 提高肺癌诊断率
Curr Oncol. 2024 Oct 2;31(10):5949-5959. doi: 10.3390/curroncol31100444.
3
Integrated analysis of microbiota and gut microbial metabolites in blood for breast cancer.

本文引用的文献

1
Streptococcus pneumoniae promotes lung cancer development and progression.肺炎链球菌促进肺癌的发生和发展。
iScience. 2023 Jan 4;26(2):105923. doi: 10.1016/j.isci.2022.105923. eCollection 2023 Feb 17.
2
Microbiota and lung cancer.微生物群与肺癌。
Semin Cancer Biol. 2022 Nov;86(Pt 3):1-10. doi: 10.1016/j.semcancer.2022.07.006. Epub 2022 Jul 23.
3
Circulating Bacterial DNA: A New Paradigm for Cancer Diagnostics.循环细菌DNA:癌症诊断的新范式
血液中微生物群和肠道微生物代谢物的综合分析在乳腺癌中的应用。
mSystems. 2024 Nov 19;9(11):e0064324. doi: 10.1128/msystems.00643-24. Epub 2024 Oct 18.
4
Microbes for lung cancer detection: feasibility and limitations.用于肺癌检测的微生物:可行性与局限性
Front Oncol. 2024 May 8;14:1361879. doi: 10.3389/fonc.2024.1361879. eCollection 2024.
5
Plasma Bacterial DNA Load as a Potential Biomarker for the Early Detection of Colorectal Cancer: A Case-Control Study.血浆细菌DNA载量作为早期检测结直肠癌的潜在生物标志物:一项病例对照研究。
Microorganisms. 2023 Sep 21;11(9):2360. doi: 10.3390/microorganisms11092360.
Front Med (Lausanne). 2022 Apr 4;9:831096. doi: 10.3389/fmed.2022.831096. eCollection 2022.
4
Detection of Circulating Tumor Cells and Microbial DNA Fragments in Stage III Colorectal Cancer Patients under Three versus Six Months of Adjuvant Treatment.III期结直肠癌患者接受三个月与六个月辅助治疗期间循环肿瘤细胞和微生物DNA片段的检测
Cancers (Basel). 2021 Jul 15;13(14):3552. doi: 10.3390/cancers13143552.
5
Detection of cell-free microbial DNA using a contaminant-controlled analysis framework.使用受污染控制分析框架检测无细胞微生物 DNA。
Genome Biol. 2021 Jun 23;22(1):187. doi: 10.1186/s13059-021-02401-3.
6
Microbiota Biomarkers for Lung Cancer.肺癌的微生物群生物标志物
Diagnostics (Basel). 2021 Feb 27;11(3):407. doi: 10.3390/diagnostics11030407.
7
Alterations of circulating bacterial DNA in colorectal cancer and adenoma: A proof-of-concept study.结直肠癌和腺瘤患者循环细菌 DNA 的改变:概念验证研究。
Cancer Lett. 2021 Feb 28;499:201-208. doi: 10.1016/j.canlet.2020.11.030. Epub 2020 Nov 27.
8
Core Microbiota in Central Lung Cancer With Streptococcal Enrichment as a Possible Diagnostic Marker.以链球菌富集为可能诊断标志物的中央型肺癌核心微生物群
Arch Bronconeumol (Engl Ed). 2020 Jun 30. doi: 10.1016/j.arbres.2020.05.034.
9
Airway Microbiota as a Modulator of Lung Cancer.气道微生物群作为肺癌的调节因子
Int J Mol Sci. 2020 Apr 26;21(9):3044. doi: 10.3390/ijms21093044.
10
The Prognostic Value of the Detection of Microbial Translocation in the Blood of Colorectal Cancer Patients.检测结直肠癌患者血液中微生物易位的预后价值
Cancers (Basel). 2020 Apr 24;12(4):1058. doi: 10.3390/cancers12041058.